Page last updated: 2024-11-06

tibalosin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tibalosin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID163028
CHEMBL ID2107043
SCHEMBL ID8974326
MeSH IDM0114106

Synonyms (9)

Synonym
tibalosin
1-(2,3-dihydro-1-benzothiophen-5-yl)-2-(4-phenylbutylamino)propan-1-ol
CHEMBL2107043
SCHEMBL8974326
FJLRGFADCXTJNV-UHFFFAOYSA-N
1-(2,3-dihydro-5-benzo[b]thienyl)-2-(4-phenylbutylamino)-1-propanol
1-(2,3-dihydro-1-benzothien-5-yl)-2-[(4-phenylbutyl)amino]-1-propanol
DTXSID70867046
1-(2,3-dihydro-1-benzothiophen-5-yl)-2-[(4-phenylbutyl)amino]propan-1-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (75.00)18.7374
1990's2 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (44.44%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (55.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]